Magnetar Financial’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,822
Closed -$1.89K 961
2024
Q4
$1.89K Hold
11,822
﹤0.01% 589
2024
Q3
$872 Hold
11,822
﹤0.01% 507
2024
Q2
$290 Hold
11,822
﹤0.01% 497
2024
Q1
$650 Hold
11,822
﹤0.01% 358
2023
Q4
$108 Buy
11,822
+231
+2% +$3 ﹤0.01% 357
2023
Q3
$347 Hold
11,591
﹤0.01% 435
2023
Q2
$82 Hold
11,591
﹤0.01% 471
2023
Q1
$214 Hold
11,591
﹤0.01% 594
2022
Q4
$0 Hold
11,591
﹤0.01% 966
2022
Q3
$2K Sell
11,591
-29,152
-72% -$8.18K ﹤0.01% 1317
2022
Q2
$10 Hold
40,743
﹤0.01% 1418
2022
Q1
$26K Buy
40,743
+588
+1% +$407 ﹤0.01% 1275
2021
Q4
$39K Buy
40,155
+2,669
+7% +$5.25K ﹤0.01% 1340
2021
Q3
$79K Sell
37,486
-163,377
-81% -$537K ﹤0.01% 1259
2021
Q2
$924 Sell
200,863
-30,614
-13% -$131K 0.01% 749
2021
Q1
$1.17M Buy
+231,477
New +$1.29M 0.01% 675

Other funds holding WGSWW

Magnetar Financial's WGSWW Position: Q1 2025 in Review

Magnetar Financial sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2025, closing a stake of 11,822 shares — an estimated $1.89K sold.

Magnetar Financial first reported a position in WGSWW in Q1 2021 and held it in 16 quarters. The position peaked at $1.17M in Q1 2021. 14 funds tracked by Wall St. Rank hold WGSWW as of Q1 2025.

  • Magnetar Financial reported no remaining GeneDx Holdings Warrant position as of Q1 2025 after selling out during the quarter.
  • Magnetar Financial sold 11,822 GeneDx Holdings Warrant shares in Q1 2025, an estimated $1.89K.
  • Magnetar Financial first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 16 quarters.
  • Magnetar Financial's GeneDx Holdings Warrant position peaked at $1.17M in Q1 2021.
  • 14 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.